No Data
No Data
No Data
No Data
No Data
Analysts Conflicted on These Healthcare Names: Gilead Sciences (GILD), Rhythm Pharmaceuticals (RYTM) and Dexcom (DXCM)
TipRanksApr 26 06:42 ET
Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
BOSTON, April 24, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare
GlobeNewswireApr 24 16:01 ET
Jim Cramer Is 'Willing To Let This Pharma Stock Catch Fire,' Advises Not To Sell McKesson
On CNBC's "Mad Money Lightning Round," Jim Cramer recommended holding ConocoPhillips (NYSE:COP)Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) is a "speculative play," Cramer said, "I am not against specul
BenzingaApr 19 08:46 ET
Rhythm Pharmaceuticals Is Maintained at Overweight by Wells Fargo
Rhythm Pharmaceuticals Is Maintained at Overweight by Wells Fargo
Dow JonesApr 18 09:09 ET
Express News | Rhythm Pharmaceuticals, Inc. : Wells Fargo Cuts Target Price to $52 From $53: Wells Fargo Cuts Target Price to $52 From $53
Moomoo 24/7Apr 18 06:54 ET
Wells Fargo Remains a Buy on Rhythm Pharmaceuticals (RYTM)
TipRanksApr 18 06:45 ET
No Data
No Data